Claims for Patent: 6,143,769

Summary for Patent: 6,143,769

Title:	Phenylacetic acid benzylamides
Abstract:	The present application relates to the uses of phenylacetic acid benzylamides and new (S)(+)-2-ethoxy-4-[N-[1-2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbon ylmethyl]-benzoic acid and the salts thereof, which have valuable pharmacological properties, namely an effect on the intermediate metabolism, but particularly the effect of lowering blood sugar.
Inventor(s):	Grell; Wolfgang (Biberach, DE), Hurnaus; Rudolf (Biberach, DE), Griss, deceased; Gerhart (late of Biberach, DE), Sauter; Robert (Laupheim, DE), Reiffen; Manfred (Biberach, DE), Rupprecht; Eckhard (Aulendorf-Tannhausen, DE)
Assignee:	Karl Thomae GmbH (Biberach an der Riss, DE)
Application Number:	08/180,587
Patent Claims:	1. Substantially optically pure (S)(+)-2-ethoxy-4[N-{1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbony lmethyl]-benzoic acid and the salts thereof with inorganic or organic acids or bases. 2. The compound according to claim 1 having an optical purity of at least ee=95%. 3. The compound according to claim 1 having an optical purity of at least ee=98%. 4. The physiologically acceptable salts of the compound according to claim 1 with organic or inorganic acids or bases. 5. A pharmaceutical composition comprising a compound according to claim 1 and one or more inert carriers or diluents. 6. A method for treating diabetes mellitus comprising administering a therapeutically effective amount of the compound as recited in claim 1.